Just as with cancer and heart disease, treating Alzheimer’s earlier leads to significantly better outcomes.
Fortunately, new FDA-cleared blood tests can now identify the disease in its earliest stages, allowing patients to access new treatments at the point when they can be most effective. This is exactly what Americans want. More than 9 in 10 Americans say they would take a simple test for Alzheimer’s.
Under current law, Medicare cannot cover any dementia screening test for people without symptoms — a legal barrier only Congress can fix. Unlike similar tests for many other diseases, until Congress acts, Medicare can’t pay for these tests.
The bipartisan ASAP Act clears the roadblock.
Congress can take this common‑sense step so people can benefit from treatment when it matters most. This is our moment to make early detection the new standard of care.
With your help in contacting your Congressman and Senator, you can help!!
Thank you.
Kisses and Hugs,
Linda